Quorum, a gathering space for business and community, at the University City Science Center (Danya Henninger/Technical.ly) Money Moves is a recurring series where we chart the raises, grants, ...
GlobalData on MSN
Genentech reports fenebrutinib phase III results for PPMS
The trial showed fenebrutinib reduced disability progression risk by 12% compared to Ocrevus, the only approved PPMS ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The South San Francisco biotech giant's experimental ...
- SanegeneBio to receive $200 million upfront payment and will be eligible to receive development and commercialization milestone payments, totaling up to $1.5 billion, plus tiered royalties - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results